Aurora Labs Ltd. (AU:A3D)
ASX:A3D
Top Page
Aurora Labs
(Sydney:A3D)
Select Model
Select Model
Rating:50Neutral
Price Target:
AU$0.05
▼(-13.33% Downside)
Action:ReiteratedDate:02/13/26
The score is held back primarily by weak financial quality—ongoing losses, negative operating cash flow, and higher leverage—despite strong top-line growth. Technicals are a meaningful offset, with price and momentum indicators signaling a solid uptrend. Valuation remains constrained because the company is loss-making (negative P/E) and no dividend yield is provided.
Positive Factors
Revenue Growth
Sustained revenue growth at this magnitude indicates accelerating market adoption of Aurora Labs' products and services. Over 2-6 months this suggests expanding customer wins, improving sales traction in industrial 3D printing, and a larger base to leverage for scale and future margin improvement.
Negative Factors
Ongoing Losses
Persistent negative net and EBIT margins constrain internal capital generation and limit reinvestment into R&D and commercial scaling. Over months this raises dependency on external funding, increases dilution risk, and weakens the firm's ability to sustain longer product development cycles common in industrial equipment markets.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained revenue growth at this magnitude indicates accelerating market adoption of Aurora Labs' products and services. Over 2-6 months this suggests expanding customer wins, improving sales traction in industrial 3D printing, and a larger base to leverage for scale and future margin improvement.
Read all positive factors
Aurora Labs (A3D) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$28.80M
Dividend YieldN/A
Average Volume (3M)733.36K
Price to Earnings (P/E)―
Beta (1Y)0.95
Revenue Growth327.10%
EPS Growth1.01%
CountryAU
Employees10
SectorIndustrials
Sector Strength72
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding523,619,600
10 Day Avg. Volume674,439
30 Day Avg. Volume733,357
Financial Highlights & Ratios
PEG Ratio1.94
Price to Book (P/B)13.71
Price to Sales (P/S)19.76
P/FCF Ratio-5.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Aurora Labs Business Overview & Revenue Model
Company Description
Aurora Labs Limited engages in the design, development, and commercialization of 3D metal printers, powders, and digital parts and its related intellectual property in Australia. It develops industrial grade 3D metal printers. The company was inco...
How the Company Makes Money
null...
Aurora Labs Financial Statement Overview
Summary
Income Statement
35
Negative
Balance Sheet
40
Negative
Cash Flow
30
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 708.31K | 743.83K | 174.30K | 134.56K | 32.20K | 171.62K |
| Gross Profit | -1.37M | 326.65K | 57.13K | 58.81K | 13.89K | -145.00K |
| EBITDA | -4.77M | -4.54M | -3.23M | -3.37M | -3.70M | -4.81M |
| Net Income | -4.05M | -3.75M | -2.81M | -2.96M | -3.15M | -4.42M |
Balance Sheet | ||||||
| Total Assets | 5.77M | 2.91M | 3.08M | 2.18M | 3.35M | 2.91M |
| Cash, Cash Equivalents and Short-Term Investments | 3.65M | 1.16M | 1.65M | 986.80K | 1.95M | 1.37M |
| Total Debt | 232.00K | 956.01K | 842.94K | 65.39K | 160.53K | 252.00K |
| Total Liabilities | 1.40M | 1.84M | 1.30M | 719.35K | 716.58K | 711.20K |
| Stockholders Equity | 4.37M | 1.07M | 1.78M | 1.46M | 2.63M | 2.20M |
Cash Flow | ||||||
| Free Cash Flow | -4.21M | -2.80M | -2.41M | -2.60M | -2.68M | -1.68M |
| Operating Cash Flow | -3.22M | -2.62M | -2.40M | -2.57M | -2.63M | -1.68M |
| Investing Cash Flow | -988.63K | -180.58K | -7.69K | -23.07K | -48.42K | 6.86K |
| Financing Cash Flow | 5.68M | 2.31M | 3.07M | 1.63M | 3.25M | 1.72M |
Aurora Labs Technical Analysis
Positive
0.06
Price Trends
0.05
Positive
0.05
Positive
0.05
Positive
Market Momentum
>-0.01
Negative
53.10
Neutral
68.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:A3D, the sentiment is Positive. The current price of 0.06 is above the 20-day moving average (MA) of 0.05, above the 50-day MA of 0.05, and above the 200-day MA of 0.05, indicating a bullish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 53.10 is Neutral, neither overbought nor oversold. The STOCH value of 68.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:A3D.
Aurora Labs Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | AU$69.37M | 8.31 | 12.00% | 1.92% | 3.55% | 4.14% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | AU$304.83M | -3.91 | -39.81% | ― | 722.02% | -0.77% | |
50 Neutral | AU$28.80M | -2.24 | -148.94% | ― | 327.10% | 1.01% | |
46 Neutral | AU$379.00M | -19.19 | -68.32% | ― | -27.57% | 24.54% | |
41 Neutral | AU$124.32M | -4.86 | -35.18% | ― | 0.88% | 4.88% | |
39 Underperform | AU$417.59M | -5.06 | -99.54% | ― | 36.97% | -25.00% |
* Industrials Sector Average
AU:A3D
Aurora Labs
0.06
<0.01
1.85%
AU:TTT
Titomic Ltd
0.26
0.09
52.94%
AU:AL3
AML3D Ltd
0.23
0.08
60.71%
AU:MPW
Metal Powder Works Limited
2.53
2.17
602.78%
AU:3DA
Amaero International Ltd
0.32
0.12
56.10%
AU:LBL
Laserbond Limited
0.59
0.26
80.56%
Aurora Labs Corporate Events
Aurora Labs Strengthens Governance With New Company Secretary
Apr 1, 2026
Aurora Labs has announced a change in its company secretary, with Grant Mooney resigning effective 10 April 2026 and Stephen Buckley stepping into the role. Buckley, a director at Governance Corporate, brings more than four decades of financial ma...
Aurora Labs Director Increases Indirect Shareholding via On-Market Trade
Mar 17, 2026
Aurora Labs Limited has reported a change in director David Trimboli’s interests, detailing additional ordinary shares acquired through his investment vehicle, Seefeld Investments Pty Ltd. Following an on-market trade on 16 March 2026, Seefe...
Aurora Labs Plans Issue of 28 Million Unlisted Options for Capital Raising
Mar 10, 2026
Aurora Labs Limited has notified the ASX of a proposed issue of up to 28 million unlisted options as part of a placement or similar capital-raising mechanism. The options, which form a new class of unlisted securities, are scheduled for issue on 9...
Aurora Labs Moves to Digital Communication for April Shareholder Meeting
Mar 9, 2026
Aurora Labs has called a general meeting of shareholders for 9 April 2026 in Perth, where resolutions will be decided by poll based on both proxy votes and those of shareholders attending in person. The company is shifting to primarily digital dis...
Aurora Labs Calls April 2026 Meeting to Vote on Director Option Grant
Mar 9, 2026
Aurora Labs Limited has called a general meeting of shareholders to be held in Perth on 9 April 2026, with proxy votes due by 7 April 2026, to consider key governance and remuneration matters. The main item on the agenda is shareholder approval fo...
Aurora Labs Appoints New Director With No Current Equity Stake
Mar 8, 2026
Aurora Labs Ltd has appointed Andrew Bottrell as a director effective 4 March 2026, according to an initial director’s interest notice lodged with the ASX. The filing shows that Bottrell holds no relevant interests in Aurora Labs securities,...
Aurora Labs Adds Senior Defence Leader to Board to Bolster Growth in Defence Markets
Mar 4, 2026
Aurora Labs has strengthened its board with the appointment of retired Major General Andrew Bottrell as a non-executive director, effective 5 March 2026, adding nearly four decades of senior defence and national security experience. Bottrell bring...
Aurora Labs Issues New Shares Under Employee Incentive Scheme
Mar 3, 2026
Aurora Labs has issued 259,924 fully paid ordinary shares as a result of the conversion of an equivalent number of share rights granted under its Employee Incentive Scheme. The move modestly increases the company’s share capital while reinfo...
Aurora Labs Director Increases Equity Stake via Share Rights Conversion
Mar 3, 2026
Aurora Labs has disclosed a change in director David Trimboli’s interests, following the issue and subsequent conversion of 259,924 share rights into ordinary shares. The transaction, valued at $11,956.52, increased Trimboli’s direct h...
Aurora Labs Seeks ASX Quotation for Additional Ordinary Shares
Mar 3, 2026
Aurora Labs Limited has applied for quotation on the ASX of 259,924 new ordinary fully paid shares, to be issued on March 3, 2026, under its existing ticker A3D. The additional securities arise from the exercise or conversion of existing options o...
Aurora Labs Issues 259,924 Unquoted Share Rights Under Employee Scheme
Feb 27, 2026
Aurora Labs Limited has notified the market of the issue of 259,924 unquoted share rights under an employee incentive scheme, with an issue date of 27 February 2026. These securities are not intended to be quoted on the ASX, indicating the company...
Aurora Labs Widens Half-Year Loss as Revenue Declines
Feb 20, 2026
Aurora Labs Limited reported revenue of $201,219 for the six months to 31 December 2025, down 15% from the prior corresponding period, highlighting ongoing commercial challenges in growing its top line. The company’s net tangible assets per ...
Aurora Labs Director Increases Shareholding Through On‑Market Purchase
Feb 9, 2026
Aurora Labs has disclosed a change in director David Trimboli’s interests in the company’s securities, following an on‑market purchase of 255,236 ordinary shares over 5–6 February 2026. The transaction, valued at $13,772.27...
Aurora Labs Enters Defence Propulsion Market With First Turbine Order and Strategic Defence MOUs
Jan 29, 2026
Aurora Labs reported progress in the December 2025 quarter as it accelerates the commercialisation of its metal additive manufacturing technology and broadens its market exposure beyond development into early-stage deployment. The company formally...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.